ArticleNature communications2026
Host mature tRNAome as a decoding switch regulates antiviral and proviral responses.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Current virus-host studies primarily concentrate on the battle race at the levels of mRNA transcription and protein translation. These processes, on both the host and virus sides, rely on the mature tRNAome to decode, yet they remain largely unexplored. In this study, we report a previously unrecognized dichotomy in the host tRNAome concerning antiviral and proviral responses. We demonstrate that the host's mature tRNAome, which is coupled with amino acid metabolism, is dynamically remodeled by interferon-alpha (IFN-α) and regulates the translation efficiencies of downstream interferon-stimulated genes (ISGs). Interference with tRNAome maturation or charging dampens the antiviral efficacy of IFN-α in hepatitis E virus (HEV)-infected cells. In contrast, hepatitis B virus (HBV) infection, which does not induce the ISG response, still remodels the host tRNAome to promote its own infection, particularly through tRNA-Arg-UCU. Both charging and genetic interference with tRNA-Arg-UCU inhibit HBV DNA replication, while its overexpression in vitro and in a male mouse model enhances HBV DNA replication and translation. Importantly, this tRNA not only facilitates the decoding of the nucleocapsid, where HBV replication initiates, but also indirectly affects pregenomic RNA (pgRNA) transcription, which encodes the nucleocapsid subunit, core protein. These findings suggest the potential for tRNA-based strategies to amplify the interferon response and develop antivirals targeting HBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.